.Pharmacolibrary.Drugs.C_CardiovascularSystem.C10A_LipidModifyingAgentsPlain.C10AX18_Volanesorsen.Volanesorsen

Information

name:Volanesorsen
ATC code:C10AX18
route:subcutaneous
n-compartments2

Volanesorsen is an antisense oligonucleotide drug designed to inhibit the synthesis of apolipoprotein C-III (ApoC-III), a protein involved in the metabolism of triglyceride-rich lipoproteins. It is primarily used for the treatment of familial chylomicronemia syndrome (FCS) in adults, a rare genetic disorder characterized by extremely elevated triglyceride levels. Volanesorsen has received conditional approvals in the EU and other selected markets.

Pharmacokinetics

Reported pharmacokinetic parameters in healthy adult volunteers and patients with hypertriglyceridemia following subcutaneous administration.

References

    Revisions

    Generated at 2025-07-21T18:21:10Z by OpenModelicaOpenModelica 1.25.1 using GenerateDoc.mos